An in vitro model of innate lymphoid cell function and differentiation

Mucosal Immunology

Volumn 8, Issue 2, 2015, Pages 340-351

  Allan, D S J ^a,b   Kirkham, C L ^a,b   Aguilar, O A ^a,b   Qu, L C ^a,b   Chen, P ^a,b   Fine, J H ^a,b   Serra, P ^a,b   Awong, G ^a,b   Gommerman, J L ^a   Zuniga Pflucker J C ^a,b   Carlyle, J R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; LYMPHOTOXIN ALPHA BETA; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TRANSCRIPTOME; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE; MEMBRANE ANTIGEN; NATURAL KILLER CELL RECEPTOR;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; IMMUNOREACTIVITY; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOID CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; THYMOCYTE; ANIMAL; CLUSTER ANALYSIS; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; METABOLISM; PHENOTYPE;

ANIMALS; ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELL LINEAGE; CLUSTER ANALYSIS; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MICE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PHENOTYPE; RECEPTORS, NATURAL KILLER CELL;

EID: 84922744283     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.71     Document Type: Article

References (58)

1. Spits, H., et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013).
2. Vosshenrich, C.A. & Di Santo, J.P. Developmental programming of natural killer and innate lymphoid cells. Curr. Opin. Immunol. 25, 130-138 (2013).
3. Bernink, J.H., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221-229 (2013).
4. Fuchs, A., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38, 769-781 (2013).
5. Vonarbourg, C., et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33, 736-751 (2010).
6. Cella, M., Otero, K. & Colonna, M. Expansion of human NK-22 cells with IL- 7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. USA 107, 10961-10966 (2010).
7. Klose, C.S., et al. A T-bet gradient controls the fate and function of CCR6- RORgammat+ innate lymphoid cells. Nature 494, 261-265 (2013).
8. Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647-675 (2012).
9. Walker, J.A. & McKenzie, A.N. Development and function of group 2 innate lymphoid cells. Curr. Opin. Immunol. 25, 148-155 (2013).
10. Finke, D. Fate and function of lymphoid tissue inducer cells. Curr. Opin. Immunol. 17, 144-150 (2005).
11. Cupedo, T., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors toRORC+ CD127+ natural killer-like cells. Nat. Immunol. 10, 66-74 (2009).
12. Sawa, S., et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12, 320-326 (2011).
13. Takatori, H., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
14. Sawa, S., et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330, 665-669 (2010).
15. Cella, M., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
16. Luci, C., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75-82 (2009).
17. Sanos, S.L., et al. RORgammat and commensalmicroflora are required for the differentiation ofmucosal interleukin 22-producingNKp46+ cells. Nat. Immunol. 10, 83-91 (2009).
18. Satoh-Takayama, N., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
19. Sonnenberg, G.F., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321-1325 (2012).
20. Hepworth, M.R., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113-117 (2013).
21. Sonnenberg, G.F., Monticelli, L.A., Elloso, M.M., Fouser, L.A. & Artis, D. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122-134 (2011).
22. Tumanov, A.V., et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe. 10, 44-53 (2011).
23. Gladiator, A., Wangler, N., Trautwein-Weidner, K. & LeibundGut-Landmann, S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 190, 521-525 (2013).
24. Zenewicz, L.A., et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
25. Hanash, A.M., et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339-350 (2012).
26. Kruglov, A.A., et al. Nonredundant function of soluble LTalpha3 produced by innate lymphoid cells in intestinal homeostasis. Science 342, 1243-1246 (2013).
27. Carlyle, J.R., et al. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J. Immunol. 162, 5917-5923 (1999).
28. Carlyle, J.R., et al. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J. Immunol. 176, 7511-7524 (2006).
29. Iizuka, K., Naidenko, O.V., Plougastel, B.F., Fremont, D.H. & Yokoyama, W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4, 801-807 (2003).
30. Carlyle, J.R., et al. Missing self-recognition of Ocil/Clr-b by inhibitory NKRP1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 101, 3527-3532 (2004).
31. Vosshenrich, C.A., et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 204, 2569-2578 (2007).
32. Blasius, A.L., Barchet, W., Cella, M. & Colonna, M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J. Exp. Med. 204, 2561-2568 (2007).
33. Hoyler, T., et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634-648 (2012).
34. Bezman, N.A., et al. Molecular definition of the identity and activation of natural killer cells. Nat. Immunol. 13, 1000-1009 (2012).
35. Heng, T.S. & Painter, M.W. Immunological Genome Project, Consortium. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091-1094 (2008).
36. Tanriver, Y. & Diefenbach, A. Transcription factors controlling development and function of innate lymphoid cells. Int. Immunol. 26, 119-128 (2014).
37. Mielke, L.A., et al. TCF-1 controls ILC2 and NKp46+RORgammat+ innate lymphocyte differentiation and protection in intestinal inflammation. J. Immunol. 191, 4383-4391 (2013).
38. Serafini, N., et al. Gata3 drives development of RORgammat+ group 3 innate lymphoid cells. J. Exp. Med. 211, 199-208 (2014).
39. Constantinides, M.G., McDonald, B.D., Verhoef, P.A. & Bendelac, A. A committed precursor to innate lymphoid cells. Nature 508, 397-401 (2014).
40. Qiu, J., et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92-104 (2012).
41. Kiss, E.A., et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565 (2011).
42. Lee, J.S., et al.AHRdrives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13, 144-151 (2012).
43. Ciofani, M., et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012).
44. Mortha, A., et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).
45. Gao, J., et al. Characterization of OP9 as authentic mesenchymal stem cell line. J. Genet. Genomics 37, 475-482 (2010).
46. Tran, J. & Kung, S.K. Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells. Mol. Ther. 15, 1331-1339 (2007).
47. Mebius, R.E., Rennert, P. &Weissman, I.L. Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493-504 (1997).
48. Kim, M.Y., et al. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 124, 166-174 (2008).
49. Randall, T.D., Carragher, D.M. & Rangel-Moreno, J. Development of secondary lymphoid organs. Annu. Rev. Immunol. 26, 627-650 (2008).
50. Dudakov, J.A., et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 336, 91-95 (2012).
51. Cherrier, M., Sawa, S. & Eberl, G. Notch, Id2, and RORgammat sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J. Exp. Med. 209, 729-740 (2012).
52. Rossi, S.W., et al. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J. Exp. Med. 204, 1267-1272 (2007).
53. Glatzer, T., et al. RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38, 1223-1235 (2013).
54. Buonocore, S., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010).
55. Rankin, L.C., et al. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat. Immunol. 14, 389-395 (2013).
56. Possot, C., et al. Notch signaling is necessary for adult, but not fetal, development of RORgammat(+) innate lymphoid cells. Nat. Immunol. 12, 949-958 (2011).
57. Carlyle, J.R., et al. Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J. Exp. Med. 186, 173-182 (1997).
58. Carlyle, J.R. & Zuniga-Pflucker, J.C. Developmental origins of thymusderived natural killer cells. In Natural Killer Cells: Basic Science and Clinical Application (Lotze, M.T. & Thomson, A.W., eds) 25-40 (Academic Press, London, UK, 2009).